Europe Contract Research Organization Market to 2025 - Regional Analysis and Forecasts By Type; End User, and Country

Contract research organization (CRO) market in Europe is expected to grow from US$ 12,476.8Mn in the year 2017 and is expected to reach US$ 22,157.62 Mn by 2025 growing at a healthy CAGR for the forecast period.

The growth of the market is driven by factors such as the rise in the number of clinical trials. On the other hand, the dearth of skilled professionals in some of the European countries is limiting the growth of the market is likely to have a negative impact on the market growth in the coming years.

The CRO industry is fragmented, with several hundred small and medium-sized limited-service providers, and a small number of large, full-service, global CROs. There are few barriers for the smaller CROs to entry into the global market, whereas a full-service CRO with global capabilities requires building the necessary infrastructure with the ability to simultaneously manage multiple complex testing services across numerous geographies, establishing the requisite relationships with strategic partners, developing relevant therapeutic and development of expertise to serve the needs of the end-users. Over the past few years, the consolidation in the CRO industry is an emerging trend. It is followed by the majority of the prime players to strengthen their service offerings and garner a significant market share in the regional CRO market. Thus it has led to the availability handful of larger CROs with broad geographic diversification, extensive therapeutic and development expertise, enormous capital and technical resources to manage the demanding drug development programs of pharmaceutical and biopharmaceutical companies.

CRO's service market is creating various opportunities that are leading to the growth of the market and industries. The current going trend in the CRO industry is for the consolidation of the market. Various large players have signed agreements, some of them have merged and acquired different companies. Some of the instances are below.

The secondary sources used for validations and data mining in the Europe contract research organization market includes Pharmaceuticals and Medical Devices Agency (PMDA), Food and Drug Administration (FDA), European Federation of Pharmaceuticals Industries Associations (EFPIA), World Health Organization (WHO), are among the others.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the European contract research organization (CRO) market.
• Highlights key business priorities to assist companies in realigning their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Europe contract research organization (CRO) market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth; offering developed and emerging markets.
• Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest concerning client products, segmentation, pricing, and distribution.